Certified by Founder
Lodge
Apnimed
start up
United States
- Cambridge, Massachusetts
- 04/05/2022
- Series C
- $62,500,000
Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders.
- Industry Pharmaceuticals
- Website https://apnimed.com/
- LinkedIn https://www.linkedin.com/company/apnimed/about/
Ricursive Intelligence | $300,000,000 | (Jan 28, 2026)
Nerd Apply | $3,200,000 | (Jan 28, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026)
Jelou AI | $10,000,000 | (Jan 28, 2026)
Concourse | $12,000,000 | (Jan 28, 2026)
Risotto | $10,000,000 | (Jan 28, 2026)
Summize | $50,000,000 | (Jan 28, 2026)
FLORA(US) | $42,000,000 | (Jan 28, 2026)
Fortitude Biomedicines | $13,000,000 | (Jan 28, 2026)
Chamelio | $10,000,000 | (Jan 28, 2026)
Opendate | $14,000,000 | (Jan 28, 2026)
Midship | $4,150,000 | (Jan 28, 2026)